… HF and post-MI trials of sacubitril-valsartan. Similarly, multiple trials of early and aggressive
use of therapies effective in chronic heart failure immediately post-MI failed to demonstrate …

… left ventricular remodeling post-myocardial infarction is correlated to the risk of heart failure
(HF), which … Third, this study emphasizes that timely use of relevant drugs in patients with AMI …

… In 147 contrast, two drugs (sacubitril-valsartan and losartan) were compared against active
controls in 148 both HFrEF and post-MI. Of note, only sacubitril-valsartan used two distinct …

… of heart failure (HF) in the early post-myocardial infarction (MI… and cardiovascular mortality6
and that sacubitril/valsartan could be … antagonist pattern of use in heart failure with reduced …

… Post-myocardial infarction heart failure (post-MI HF) is a common, life-threatening complication
in patients … All data in this study were used to determine the means and SDs. Student's t …

… infarction are at a high risk of developing heart failure. The … sacubitril/valsartan 97/103 mg
twice daily with valsartan 160 … A strength of the present trial was the use of valsartan as the …

… (sacubitril/valsartan) can lower the risk of cardiovascular events in chronic heart failure. …
patients with acute myocardial infarction (MI). The present study shows that LCZ696 can prevent …

… patients randomly assigned to sacubitril/valsartan, versus enalapril, according to background
use … Because β-blockers were used in the vast majority of patients, we could not carry out a …

… for Sacubitril/Valsartan in heart failure and post-myocardial infarction remodeling, using an
… myocardial infarction in swine was analyzed to address post-infarction ventricular remodeling…

… mortality after high-risk acute myocardial infarction (AMI) and ii) compare the effects of
sacubitril/valsartan with the ACE inhibitor ramipril across heart failure (HF) risk categories. …